Historical Valuation
DAMAI ENT (01060) is now in the Fair zone, suggesting that its current forward PS ratio of 2.83 is considered Fairly compared with the five-year average of 14.55. The fair price of DAMAI ENT (01060) is between 0.45 to 1.22 according to relative valuation methord.
Relative Value
Fair Zone
0.45-1.22
Current Price：0.92
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
DAMAI ENT (01060) has a current Price-to-Book (P/B) ratio of 1.46. Compared to its 3-year average P/B ratio of 1.00 , the current P/B ratio is approximately 46.26% higher. Relative to its 5-year average P/B ratio of 1.11, the current P/B ratio is about 31.92% higher. DAMAI ENT (01060) has a Forward Free Cash Flow (FCF) yield of approximately 5.18%. Compared to its 3-year average FCF yield of 2.49%, the current FCF yield is approximately 107.97% lower. Relative to its 5-year average FCF yield of 1.29% , the current FCF yield is about 302.12% lower.
Performance Decomposition
AI Analysis
1Y
3Y
5Y
Market capitalization of 01060 increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of 01060 in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is 01060 currently overvalued or undervalued?
DAMAI ENT (01060) is now in the Fair zone, suggesting that its current forward PS ratio of 2.83 is considered Fairly compared with the five-year average of 14.55. The fair price of DAMAI ENT (01060) is between 0.45 to 1.22 according to relative valuation methord.
What is DAMAI ENT (01060) fair value?
01060's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of DAMAI ENT (01060) is between 0.45 to 1.22 according to relative valuation methord.
How does 01060's valuation metrics compare to the industry average?
The average P/S ratio for 01060's competitors is , providing a benchmark for relative valuation. DAMAI ENT Corp (01060) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for DAMAI ENT (01060) as of Jan 15 2026?
As of Jan 15 2026, DAMAI ENT (01060) has a P/B ratio of 1.46. This indicates that the market values 01060 at 1.46 times its book value.
What is the current FCF Yield for DAMAI ENT (01060) as of Jan 15 2026?
As of Jan 15 2026, DAMAI ENT (01060) has a FCF Yield of 5.18%. This means that for every dollar of DAMAI ENT’s market capitalization, the company generates 5.18 cents in free cash flow.
What is the current Forward P/E ratio for DAMAI ENT (01060) as of Jan 15 2026?
As of Jan 15 2026, DAMAI ENT (01060) has a Forward P/E ratio of 23.01. This means the market is willing to pay $23.01 for every dollar of DAMAI ENT’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for DAMAI ENT (01060) as of Jan 15 2026?
As of Jan 15 2026, DAMAI ENT (01060) has a Forward P/S ratio of 2.83. This means the market is valuing 01060 at $2.83 for every dollar of expected revenue over the next 12 months.